Contract 75A50123C00034
Nuvox Pharma, L.L.C. · Department Of Health And Human Services · August 28, 2025
Nuvox Pharma, L.L.C. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 28, 2025 for $356,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Tucson, AZ. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $356,000.
Contract details
- PIID
- 75A50123C00034
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Tucson, AZ
- First action
- August 28, 2025
Description
RESEARCH AND DEVELOPMENT SERVICES FOR DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02
Modification timeline
-
August 28, 2025Mod P00004 · Supplemental Agreement For Work Within Scope$356.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123C00034?
Contract 75A50123C00034 is a federal contract awarded to Nuvox Pharma, L.L.C. by Department Of Health And Human Services on August 28, 2025 for $356,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50123C00034?
Nuvox Pharma, L.L.C. won contract 75A50123C00034 from Department Of Health And Human Services.
How much is contract 75A50123C00034 worth?
Contract 75A50123C00034 has obligated $0 to date but carries a potential ceiling of $356,000 if fully funded and all options are exercised.